Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer’s Disease
Restricted accessResearch articleFirst published online February 20, 2017
Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer’s Disease
Recent work has suggested that exercise may be beneficial in preventing or ameliorating symptoms of several neurological disorders, although the mechanism is not entirely understood. The current study was designed to examine the potential beneficial effect of treadmill exercise upon cognitive function in a streptozotocin (STZ)-induced rat model of Alzheimer’s disease (AD). Animals underwent treadmill exercise (30 min/day, 5 days/week) for 4 weeks after bilateral STZ intracerebroventricular injection (2.4 mg/kg). We demonstrated that treadmill exercise significantly attenuated STZ-induced neurodegeneration in the rat hippocampal CA1 region and strongly preserved hippocampal-dependent cognitive functioning. Further mechanistic investigation displayed a marked suppression of STZ-induced amyloid-β accumulation and tau phosphorylation. Intriguingly, treadmill exercise remarkably inhibited reactive gliosis following STZ insult and effectively shifted activated microglia from a pro-inflammatory M1 to an anti-inflammatory M2 phenotype, which was correlated with a significantly reduced expression of pro-inflammatory mediators and a corresponding enhancement of anti-inflammatory cytokine expression in the hippocampus. Furthermore, treadmill exercise caused a robust suppression of oxidative damage as evidenced by significantly reduced peroxynitrite production, lipid peroxidation, and oxidized DNA damage. Finally, treadmill exercise strongly attenuated STZ-induced mitochondrial dysfunction manifested by a dramatically elevated intra-mitochondrial cytochrome c oxidase activity and ATP synthesis, and markedly inhibited neuronal apoptosis in the hippocampus. These findings demonstrate that treadmill exercise has a multifactorial effect to attenuate many of the pathological processes that play a key role in AD, and provide further support for the beneficial role of exercise as a potential therapeutic option in AD treatment.
MyhrerT (2003) Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev41, 268–287.
2.
SimonianNA, CoyleJT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol36, 83–106.
3.
BehlC, HolsboerF (1998) Oxidative stress in the pathogenesis of Alzheimer’s disease and antioxidant neuroprotection. Fortschr Neurol Psychiatr66, 113–121.
4.
KoliatsosVE, KecojevicA, TroncosoJC, GastardMC, BennettDA, SchneiderJA (2006) Early involvement of small inhibitory cortical interneurons in Alzheimer’s disease. Acta Neuropathol112, 147–162.
5.
AkamaKT, Van EldikLJ (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem275, 7918–7924.
GriffinWS, MrakRE (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease. J Leukoc Biol72, 233–238.
8.
WilkinsHM, CarlSM, WeberSG, RamanujanSA, FestoffBW, LinsemanDA, SwerdlowRH (2005) Mitochondrial lysates induce inflammation and Alzheimer’s disease-relevant changes in microglial and neuronal cells. J Alzheimers Dis45, 305–318.
9.
KigerlKA, GenselJC, AnkenyDP, AlexanderJK, DonnellyDJ, PopovichPG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci29, 13435–13444.
10.
DurafourtBA, MooreCS, ZammitDA, JohnsonTA, ZaguiaF, GuiotMC, Bar-OrA, AntelJP (2012) Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia60, 717–727
.
11.
GoerdtS, PolitzO, SchledzewskiK, BirkR, GratchevA, GuillotP, HakiyN, KlemkeCD, DippelE, KodeljaV, OrfanosCE (1999) Alternative versus classical activation of macrophages. Pathobiology67, 222–226.
ZhuD, YangN, LiuYY, ZhengJ, JiC, ZuoPP (2016) M2 macrophage transplantation ameliorates cognitive dysfunction in amyloid-β-treated rats through regulation of microglial polarization. J Alzheimers Dis52, 483–495.
14.
JiangT, ZhangYD, ChenQ, GaoQ, ZhuXC, ZhouJS, ShiJQ, LuH, TanL, YuJT (2016) TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Neuropharmacology105, 196–206.
15.
MoreiraPI, CarvalhoC, ZhuX, SmithMA, PerryG (2010) Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta1802, 2–10.
16.
MoreiraPI, DuarteAI, SantosMS, RegoAC, OliveiraCR (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease. J Alzheimers Dis16, 741–761.
17.
von BernhardiR, Eugenín-von BernhardiL, EugenínJ (2015) Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci7, 124.
18.
WangX, WangW, LiL, PerryG, LeeHG, ZhuX (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta1842, 1240–1247.
19.
MufsonEJ, ChenEY, CochranEJ, BeckettLA, BennettDA, KordowerJH (1999) Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol158, 469–490.
YamaneT, IkariY, NishioT, IshiiK, IshiiK, KatoT, ItoK, SilvermanDH, SendaM, AsadaT, AraiH, SugishitaM, IwatsuboT, Study J-ADNI, Group (2014) Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: Inter-rater concordance and relationship to automated quantitative evaluation. AJNR Am J Neuroradiol35, 244–249.
23.
ShokouhiS, ClaassenD, KangH, DingZ, RogersB, MishraA, RiddleWR, Alzheimer’s Disease Neuroimaging Initiative (2013) Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET. J Nucl Med54, 1564–1569.
24.
LandauSM, HarveyD, MadisonCM, KoeppeRA, ReimanEM, FosterNL, WeinerMW, JagustWJ, Alzheimer’s Disease Neuroimaging Initiative (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging32, 1207–1218.
25.
de la TorreJC (2008) Pathophysiology of neuronal energy crisis in Alzheimer’s disease. Neurodegener Dis5, 126–132.
26.
PariharMS, BrewerGJ (2007) Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol292, C8–23.
27.
PlaschkeK, HoyerS (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci11, 477–483.
28.
Lester-CollN, RiveraEJ, SosciaSJ, DoironK, WandsJR, de la MonteSM (2006) Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease. J Alzheimers Dis9, 13–33.
29.
HoyerS, LannertH (1999) Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann N Y Acad Sci893, 301–303.
30.
Salkovic-PetrisicM, HoyerS (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach. J Neural Transm Suppl72, 217–233.
31.
GrünblattE, Salkovic-PetrisicM, OsmanovicJ, RiedererP, HoyerS (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem101, 757–770.
32.
AgrawalR, TyagiE, ShuklaR, NathC (2009) A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology56, 779–787.
33.
IshratT, ParveenK, KhanMM, KhuwajaG, KhanMB, YousufS, AhmadA, ShrivastavP, IslamF (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. Brain Res1281, 117–127.
34.
SantosDB, ColleD, MoreiraEL, PeresKC, RibeiroRP, dos SantosAA, de OliveiraJ, HortMA, de BemAF, FarinaM (2015) Probucol mitigates streptozotocin-induced cognitive and biochemical changes in mice. Neuroscience284, 590–600.
35.
ZhaoSS, YangWN, JinH, MaKG, FengGF (2015) Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. Neurotoxicology51, 166–171.
36.
BlackJE, IsaacsKR, GreenoughWT (1991) Usual vs. successful aging: Some notes on experiential factors. Neurobiol Aging12, 325–328.
37.
ChoJY, UmHS, KangEB, ChoIH, KimCH, ChoJS, HwangDY (2010) The combination of exercise training and alpha-lipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer’s disease in NSE/APPsw-transgenic mice. Int J Mol Med25, 337–346.
38.
SwainRA, HarrisAB, WienerEC, DutkaMV, MorrisHD, TheienBE, KondaS, EngbergK, LauterburPC, GreenoughWT (2003) Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience117, 1037–1046.
39.
UmHS, KangEB, KooJH, KimHT, Jin-Lee, KimEJ, YangCH, AnGY, ChoIH, ChoJY (2011) Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease. Neurosci Res69, 161–173.
40.
TrejoJL, CarroE, Torres-AlemanI (2001) Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci21, 1628–1634.
41.
ChoiDH, KwonIS, KooJH, JangYC, KangEB, ByunJE, UmHS, ParkHS, YeomDC, ChoIH, ChoJY (2014) The effect of treadmill exercise on inflammatory responses in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. J Exerc Nutrition Biochem18, 225–233.
42.
KangEB, ChoJY (2014) Effects of treadmill exercise on brain insulin signaling and β-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats. J Exerc Nutrition Biochem18, 89–96.
43.
ZhangQG, RazL, WangR, HanD, De SevillaL, YangF, VadlamudiRK, BrannDW (2009) Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci29, 13823–13836.
44.
ZhangQG, WangR, KhanM, MaheshV, BrannDW (2008) Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci28, 8430–8441.
45.
HanD, ScottEL, DongY, RazL, WangR, ZhangQ (2015) Attenuation of mitochondrial and nuclear p38α signaling: A novel mechanism of estrogen neuroprotection in cerebral ischemia. Mol Cell Endocrinol400, 21–31.
46.
LuQ, TuckerD, DongY, ZhaoN, ZhangQ (2016) Neuroprotective and functional improvement effects of methylene blue in global cerebral ischemia. Mol Neurobiol53, 5344–5355.
BarnesCA, JungMW, McNaughtonBL, KorolDL, AndreassonK, WorleyPF (1994) LTP saturation and spatial learning disruption: Effects of task variables and saturation levels. J Neurosci14, 5793–5806.
49.
CohenRM, Rezai-ZadehK, WeitzTM, RentsendorjA, GateD, SpivakI, BholatY, VasilevkoV, GlabeCG, BreunigJJ, RakicP, DavtyanH, AgadjanyanMG, KepeV, BarrioJR, BannykhS, SzekelyCA, PechnickRN, TownT (2013) A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric Aβ, and frank neuronal loss. J Neurosci33, 6245–6256.
50.
NagataK, Nakashima-KamimuraN, MikamiT, OhsawaI, OhtaS (2009) Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology34, 501–508.
51.
WanH, AggletonJP, BrownMW (1999) Different contributions of the hippocampus and perirhinal cortex to recognition memory. J Neurosci19, 1142–1148.
52.
NunomuraA, PerryG, AlievG, HiraiK, TakedaA, BalrajEK, JonesPK, GhanbariH, WatayaT, ShimohamaS, ChibaS, AtwoodCS, PetersenRB, SmithMA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol60, 759–767.
53.
ChoiDY, LeeYJ, HongJT, LeeHJ (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease. Brain Res Bull87, 144–153.
54.
KellerJN, KindyMS, HoltsbergFW, St ClairDK, YenHC, GermeyerA, SteinerSM, Bruce-KellerAJ, HutchinsJB, MattsonMP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci18, 687–697.
CorreiaSC, SantosRX, SantosMS, CasadesusG, LamannaJC, PerryG, SmithMA, MoreiraPI (2013) Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer’s disease. Curr Alzheimer Res10, 406–419.
ZhuD, YangN, LiuYY, ZhengJ, JiC, ZuoPP (2016) M2 macrophage transplantation ameliorates cognitive dysfunction in amyloid-β-treated rats through regulation of microglial polarization. J Alzheimers Dis52, 483–495.
65.
De FeliceFG, FerreiraST (2014) Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes63, 2262–2272.
66.
WitteME, GeurtsJJ, de VriesHE, van der ValkP, van HorssenJ (2010) Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?Mitochondrion10, 411–418.
67.
UrrutiaPJ, MenaNP, NÚÑezMT (2014) The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol5, 38.
68.
WangX, WangW, LiL, PerryG, LeeHG, ZhuX (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta1842, 1240–1247.
69.
YamaneT, IkariY, NishioT, IshiiK, IshiiK, KatoT, ItoK, SilvermanDH, SendaM, AsadaT, AraiH, SugishitaM, IwatsuboT, Study J-ADNI, Group (2014) Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: Inter-rater concordance and relationship to automated quantitative evaluation. AJNR Am J Neuroradiol35, 244–249.
70.
ShokouhiS, ClaassenD, KangH, DingZ, RogersB, MishraA, RiddleWR, Alzheimer’s Disease Neuroimaging Initiative (2013) Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET. J Nucl Med54, 1564–1569.
71.
LandauSM, HarveyD, MadisonCM, KoeppeRA, ReimanEM, FosterNL, WeinerMW, JagustWJ, Alzheimer’s Disease Neuroimaging Initiative (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging32, 1207–1218.
72.
TerniB, BoadaJ, Portero-OtinM, PamplonaR, FerrerI (2010) Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer’s disease pathology. Brain Pathol20, 222–233.
73.
PettegrewJW, PanchalingamK, KlunkWE, McClureRJ, MuenzLR (1994) Alterations of cerebral metabolism in probable Alzheimer’s disease: A preliminary study. Neurobiol Aging15, 117–132.
